酶替代疗法和婴儿代谢障碍的其他治疗前沿
Hyo-Jung Choi1, Achyuth Sriram1, Carla Sargiotto2
1Division of Neonatology, Department of Pediatrics, University of California, Los Angeles, Los Angeles, California.
NeoReviews
|November 30, 2025
概括
酶替代疗法 (ERT) 改变了婴儿遗传代谢障碍的治疗方法,改善了佩病等疾病的存活率. 创新和扩大接入是克服ERT挑战和改善患者结果的关键.
科学领域:
- 生物化学 生物化学
- 遗传学 遗传学 是一个
- 儿科医学 儿科医学
背景情况:
- 代谢的先天性错误 (IEMs) 是遗传性疾病,由于酶缺陷导致有毒积累或产品缺乏.
- 酶替代疗法 (ERT) 是一种关键的治疗方法,特别是在婴儿佩病等溶酶体储存障碍方面.
研究的目的:
- 审查ERT对于新生儿和婴儿代谢障碍的演变,应用和创新.
- 用佩病作为模型来强调ERT的好处和局限性.
- 探索IEMs的新兴疗法和策略.
主要方法:
- 审查有关酶替代疗法对代谢先天性错误的现有文献.
- 对婴儿发病疾病,特别是佩病的临床应用和结果的分析.
- 在ERT中讨论新的治疗方法和挑战.
主要成果:
- 以佩病重组酸α-葡萄糖酶为例的ERT显著改善了婴儿的存活率和心脏功能.
- 挑战包括免疫性,有限的中枢神经系统透和可变的疗效.
- 在子宫内ERT显示为早期干预和免疫耐受性有前途.
结论:
- ERT重新塑造了严重儿科代谢障碍的预后,提供了更好的生存率和生活质量.
- 解决高成本,访问和长期监测对于ERT更广泛的影响至关重要.
- 基因疗法,基因编辑和其他策略提供补充或替代治疗途径.
更多相关视频
相关概念视频
Pharmacokinetics in Pediatric Patients: Drug Metabolism
176
In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
176
Inborn Errors of Metabolism
683
Phenylketonuria (PKU) is a protein metabolism disorder characterized by high blood levels of the amino acid phenylalanine. This results from a mutation in the gene responsible for phenylalanine hydroxylase, an enzyme that converts phenylalanine into tyrosine. When this enzyme is deficient, phenylalanine builds up in the blood, leading to symptoms such as vomiting, rashes, seizures, growth deficiency, and severe mental retardation. An early diagnosis and a diet restricting phenylalanine intake...
683
Continuous Renal Replacement Therapy
752
Continuous Renal Replacement Therapy, also known as CRRT, is a procedural treatment for acute kidney injury (AKI) that gradually removes uremic toxins and fluids while maintaining acid-base balance and stabilizing electrolytes. It is particularly useful for hemodynamically unstable patients. Unlike intermittent hemodialysis, which is faster, CRRT provides a gentler approach over 24 hours, closely mimicking the function of natural kidneys. However, CRRT is not ideal for patients with...
752
Pharmacokinetics in Pediatric Patients: Drug Excretion
195
In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
195
Extracorporeal Removal of Drugs: Continuous Renal Replacement Therapy
164
Continuous Renal Replacement Therapy (CRRT) is an essential intervention for patients experiencing severe kidney dysfunction. This therapy offers a continuous mechanism for removing fluids and toxins from the bloodstream, leveraging the patient’s blood pressure to facilitate filtration through a specialized filter. This method contrasts with intermittent dialysis, providing a gentler and more consistent removal of waste products and excess fluid, which is particularly beneficial in...
164
Gene Therapy
27.3K
Gene therapy is a technique where a gene is inserted into a person’s cells to prevent or treat a serious disease. The added gene may be a healthy version of the gene that is mutated in the patient, or it could be a different gene that inactivates or compensates for the patient’s disease-causing gene. For example, in patients with severe combined immunodeficiency (SCID) due to a mutation in the gene for the enzyme adenosine deaminase, a functioning version of the gene can be...
27.3K


